Named the new use of aspirin in the fight against a particularly dangerous cancer



Scientists from Leeds University have shown that aspirin, as well as eicosapentaenoic acid (EPA) reduce the number of precancerous polyps in patients with a high risk of colon cancer. About it reported in a press release on MedicalXpress.

The study involved more than 700 patients from 53 hospitals in England, including a colonoscopy were identified at high risk of developing colon cancer. All volunteers were randomly divided into four groups depending on the type of treatment. Every day during the year, participants took either 300 milligrams of aspirin, or two grams of eicosapentaenoic acid, or a combination of aspirin and EPA or a placebo.

At the end of the study, volunteers who took aspirin, the total number of polyps decreased by 22 percent, and those who took EPA nine percent, although the difference between them and placebo group was not statistically significant. However, the left side of the intestine in the second group the number of polyps decreased by 25 percent.

Bowel cancer is one of the most deadly types of cancer. Despite a national screening programme in England and Wales in 2014 from this disease died 16 thousand people.

Video, photo All from Russia.


Please enter your comment!
Please enter your name here